Senti Biosciences (SNTI) Enterprise Value (2021 - 2025)
Senti Biosciences (SNTI) has 5 years of Enterprise Value data on record, last reported at -$21.6 million in Q2 2025.
- For Q2 2025, Enterprise Value fell 35.7% year-over-year to -$21.6 million; the TTM value through Jun 2025 reached -$21.6 million, down 35.7%, while the annual FY2024 figure was -$48.3 million, 34.44% down from the prior year.
- Enterprise Value reached -$21.6 million in Q2 2025 per SNTI's latest filing, up from -$33.8 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$10.5 million in Q3 2024 and bottomed at -$139.8 million in Q2 2022.
- Average Enterprise Value over 5 years is -$54.4 million, with a median of -$39.4 million recorded in 2023.
- Peak YoY movement for Enterprise Value: tumbled 75.9% in 2022, then surged 73.42% in 2024.
- A 5-year view of Enterprise Value shows it stood at -$56.0 million in 2021, then crashed by 75.9% to -$98.6 million in 2022, then soared by 63.55% to -$35.9 million in 2023, then tumbled by 34.44% to -$48.3 million in 2024, then surged by 55.33% to -$21.6 million in 2025.
- Per Business Quant database, its latest 3 readings for Enterprise Value were -$21.6 million in Q2 2025, -$33.8 million in Q1 2025, and -$48.3 million in Q4 2024.